Dermatological Drugs - Taiwan

Taiwan

Highlights

The Dermatological Drugs market in Taiwan is expected to experience significant growth in the coming years.
According to projections, the revenue in this market is projected to reach US$74.18m in 2024.
Furthermore, it is anticipated that the market will continue to expand at an annual growth rate of 5.52% from 2024 to 2029, resulting in a market volume of US$97.03m by 2029.
When compared to other countries, United States is expected to generate the highest revenue in the Dermatological Drugs market, with an estimated revenue of US$11.67bn in 2024.
Taiwan's dermatological drug market is witnessing a surge in demand for skincare products with natural ingredients.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Taiwan, known for its bustling cities and beautiful landscapes, has a growing market for dermatological drugs. With a high demand for skincare products and a culture that values healthy and youthful-looking skin, the dermatological drugs market in Taiwan has seen significant growth in recent years.

Customer preferences: Taiwanese consumers are increasingly concerned with their skin's health and appearance, leading to a rise in demand for dermatological drugs. The market is driven by a desire for products that address specific skin concerns, such as acne, hyperpigmentation, and aging. Additionally, consumers in Taiwan prefer products that are natural and free from harmful chemicals.

Trends in the market: One trend in the Taiwanese dermatological drugs market is the growing popularity of K-beauty products. Korean skincare brands are highly sought after by Taiwanese consumers due to their innovative and effective formulations. Another trend is the increasing use of technology in skincare. Consumers are turning to digital tools such as apps and devices to help them track their skin's health and find the right products for their needs.

Local special circumstances: Taiwan has a strong pharmaceutical industry, which has contributed to the growth of the dermatological drugs market. The country is home to several local skincare brands that cater to the unique needs of Taiwanese consumers. Additionally, Taiwan has a well-established medical tourism industry, with many visitors seeking dermatological treatments and products.

Underlying macroeconomic factors: Taiwan's economy has been steadily growing in recent years, which has led to an increase in disposable income and consumer spending. This has contributed to the growth of the dermatological drugs market, as consumers are willing to invest in high-quality skincare products. Additionally, Taiwan has a large aging population, which has created a demand for anti-aging skincare products. In conclusion, the dermatological drugs market in Taiwan is growing due to increasing consumer demand for skincare products that address specific concerns and are free from harmful chemicals. Trends such as the popularity of K-beauty and the use of technology in skincare are driving growth in the market. Local skincare brands and Taiwan's medical tourism industry are also contributing to the market's growth. Overall, Taiwan's strong economy and aging population are creating a favorable environment for the dermatological drugs market to thrive.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.